Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist
- 1 May 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 150 (1-2) , 9-14
- https://doi.org/10.1016/0014-2999(88)90744-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tremorigenic Effect and Inhibition of Tryptamine and Serotonin Receptor Binding by β‐CarbolinesBasic & Clinical Pharmacology & Toxicology, 1987
- EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α2‐ADRENORECEPTORSJournal of Autonomic Pharmacology, 1986
- Affinity of Various Compounds for Benzodiazepine Binding Sites in Rat Brain, Heart and Kidneys in VitroActa Pharmacologica et Toxicologica, 1986
- Evaluation of the α1- and α2-adrenoceptor effects of detomidine, a novel veterinary sedative analgesicEuropean Journal of Pharmacology, 1985
- Binding of β‐Carbolines and Tetrahydroisoquinolines by Opiate Receptors of the δ‐TypeActa Pharmacologica et Toxicologica, 1984
- Does clonidine alter anxiety in humans?Trends in Pharmacological Sciences, 1982
- α-Adrenoceptor subclassificationPublished by Springer Nature ,1981
- Pharmacology of ClonidineJournal of Cardiovascular Pharmacology, 1980
- A functional basis for classification of α-adrenergic receptorsLife Sciences, 1977
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973